Raze Therapeutics Receives $24,000,000 Series A Funding Round

  • Feed Type
  • Date
    10/14/2014
  • Company Name
    Raze Therapeutics
  • Mailing Address
    25 First Street Cambridge, MA 02141 USA
  • Company Description
    Raze Therapeutics is a biotechnology company dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways driving cancer growth and survival.
  • Website
    http://www.razetx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $24,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to advance the development of a new class of therapeutics that fight cancer by targeting mitochondrial one-carbon (1C) metabolism – fundamental metabolic pathways necessary for tumors to grow and survive.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy